Publications by authors named "I-Chen Su"
Article Synopsis
- The study focuses on the impact of anti-glutamic acid decarboxylase (anti-GAD) antibodies in children with encephalitis/encephalopathy, highlighting the limited research on their clinical relevance.
- A total of 37 hospitalized children were analyzed and categorized into high-titer and low-titer groups based on their anti-GAD antibody levels.
- High titers were linked to initial symptoms like language difficulties and ataxia, but the antibody levels did not correlate with overall severity or patient outcomes; immunotherapy led to fluctuating antibody levels and variable clinical responses.*
Background: The aim of this study was to examine the predictive value of amplitude-integrated electroencephalography (aEEG) on 12-month seizure outcomes of infants with neonatal hypoxic-ischemic encephalopathy (HIE) treated with therapeutic hypothermia.
Methods: We conducted this retrospective cohort study in a tertiary neonatal intensive care unit between May 2012 and September 2017. Neonates with HIE who received both therapeutic hypothermia (TH) and aEEG were enrolled.
Background: Ginsenoside Rg1 has been shown to clear senescence-associated beta-galactosidase (SA-β-gal) in cultured cells. It remains unknown whether Rg1 can influence SA-β-gal in exercising human skeletal muscle.
Methods: To examine SA-β-gal change, 12 young men (age 21 ± 0.
Background: Myasthenia gravis is the most common disease affecting the neuromuscular junction. The most common etiology among patients with juvenile myasthenia gravis is the production of antibodies against the acetylcholine receptor. However, the clinical outcome in relation to serum levels of anti-acetylcholine receptor antibodies in juvenile myasthenia gravis has rarely been discussed.
View Article and Find Full Text PDFBackground: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an anti-neuronal antibody-mediated inflammatory brain disease that causes severe psychiatric and neurological deficits in previously healthy patients. The aims of this study were to demonstrate the clinical characteristics of patients diagnosed with anti-NMDA receptor encephalitis and to compare the different treatment strategies among these patients.
Methods: Patients presenting with newly acquired psychiatric and/or neurological deficits were studied retrospectively from 2009 to 2017.